Source comparison
CJC-1295 no DAC & Ipamorelin Air Bubbles: Injection Route Comparison
Intravenous 3–5mL/kg body weight Air enters venous circulation → right atrium → pulmonary artery obstruction Not applicable. Peptides are never administered IV Zero risk at subcutaneous volumes Intramuscular 10–50mL localized Air trapped in muscle tissue cause
This comparison does not assign a generated winner or score.
- Intravenous
- 3–5mL/kg body weight
- Air enters venous circulation → right atrium → pulmonary artery obstruction
- Not applicable. Peptides are never administered IV
- Zero risk at subcutaneous volumes
- Intramuscular
- 10–50mL localized
- Air trapped in muscle tissue causes temporary discomfort, absorbed over 48–72 hours
- Rare administration route for these peptides; IM injection would require 1mL+ volumes
- Minimal risk; absorption timelines eliminate concern
- Subcutaneous
- 10mL+ for palpable emphysema
- Air deposits in adipose tissue with minimal vascular access; creates crepitus if excessive
- Standard route for CJC-1295 & Ipamorelin at 0.2–0.5mL volumes
- Physiologically impossible to reach risk threshold at protocol volumes